Status:
COMPLETED
DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Childhood Acute Lymphoblastic Leukemia in Remission
Recurrent Childhood Acute Lymphoblastic Leukemia
Eligibility:
All Genders
Up to 18 years
Brief Summary
This laboratory study is looking at DNA in tumor tissue samples from young patients with acute lymphoblastic leukemia. DNA analysis of tumor tissue may help doctors predict how well patients will resp...
Detailed Description
PRIMARY OBJECTIVE: I. To validate significant associations between SNPs and treatment outcome and toxicity on Children's Cancer Group (CCG)-1891 on an independent sample set from a successor CCG stud...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Enrolled in clinical trial CCG-1891 or CCG-1952 with pediatric ALL
Exclusion
Key Trial Info
Start Date :
May 13 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
520 Patients enrolled
Trial Details
Trial ID
NCT00897507
Start Date
May 13 2004
Last Update
August 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Oncology Group
Philadelphia, Pennsylvania, United States, 19104